Ginkgo Bioworks stock rises after securing $4.66M automation contract

Published 30/07/2025, 17:00
© Reuters.

Investing.com -- Ginkgo Bioworks Holdings (NYSE:DNA) stock rose 2.6% after the cell programming and biosecurity platform company announced a $4.66 million contract to deliver an automated anaerobic phenotyping platform to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory (PNNL).

Under the agreement, Ginkgo will construct and install a fully integrated workcell comprising 18 different devices housed within a modular anaerobic chamber at EMSL’s Richland, Washington campus. The system will utilize Ginkgo Automation’s Reconfigurable Automation Cart technology, designed to enhance laboratory throughput, efficiency, and data quality.

The platform aims to enable EMSL scientists to remotely operate complex end-to-end anaerobic phenotyping workflows, potentially streamlining research processes in support of U.S. energy production and bioeconomy initiatives. Ginkgo’s technology includes a web-based software stack designed for programmatic control via API gateway access, which could enable AI-driven autonomous science capabilities.

"We are excited to support EMSL’s ambitious research goals with our automation technology," said Will Serber, General Manager of Ginkgo Automation. "Our automated systems are designed to empower partners like EMSL to realize the benefits of automation for research and development while maintaining control over their scientific workflows."

The company indicated that similar automation systems have been deployed across Ginkgo labs and at external customer sites, delivering increased throughput and data capture while decreasing cycle times and costs. The new platform is expected to be fully operational at EMSL later this year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.